{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:49:54Z","timestamp":1788569394207,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T00:00:00Z","timestamp":1355875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s12185-012-1234-3","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T07:26:11Z","timestamp":1355815571000},"page":"73-82","source":"Crossref","is-referenced-by-count":23,"title":["Effects of insulin-like growth factor-1 on B-cell precursor acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"97","author":[{"given":"Hiroyuki","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Miharu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Okita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Kiyokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,19]]},"reference":[{"key":"1234_CR1","doi-asserted-by":"crossref","first-page":"9389","DOI":"10.1021\/bi020084j","volume":"41","author":"AM Brzozowski","year":"2002","unstructured":"Brzozowski AM, Dodson EJ, Dodson GG, Murshudov GN, Verma C, Turkenburg JP, et al. Structural origins of the functional divergence of human insulin-like growth factor-I and insulin. Biochemistry. 2002;41:9389\u201397.","journal-title":"Biochemistry"},{"key":"1234_CR2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd917","volume":"1","author":"P Meyts De","year":"2002","unstructured":"De Meyts P, Whittaker J. Structural biology of insulin and IGF1 receptors: implications for drug design. Nat Rev Drug Discov. 2002;1:769\u201383.","journal-title":"Nat Rev Drug Discov"},{"key":"1234_CR3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","volume":"7","author":"CM Taniguchi","year":"2006","unstructured":"Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. 2006;7:85\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1234_CR4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0022-5347(05)63999-7","volume":"169","author":"H Zhao","year":"2003","unstructured":"Zhao H, Grossman HB, Spitz MR, Lerner SP, Zhang K, Wu X. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol. 2003;169:714\u20137.","journal-title":"J Urol"},{"key":"1234_CR5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1634\/theoncologist.2007-0199","volume":"13","author":"PD Ryan","year":"2008","unstructured":"Ryan PD, Goss PE. The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer. Oncologist. 2008;13:16\u201324.","journal-title":"Oncologist"},{"key":"1234_CR6","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","volume":"351","author":"SE Hankinson","year":"1998","unstructured":"Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet. 1998;351:1393\u20136.","journal-title":"Lancet"},{"key":"1234_CR7","first-page":"655","volume":"11","author":"U Hermanto","year":"2000","unstructured":"Hermanto U, Zong CS, Wang LH. Inhibition of mitogen-activated protein kinase kinase selectively inhibits cell proliferation in human breast cancer cells displaying enhanced insulin-like growth factor I-mediated mitogen-activated protein kinase activation. Cell Growth Differ. 2000;11:655\u201364.","journal-title":"Cell Growth Differ"},{"key":"1234_CR8","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/jnci\/91.7.620","volume":"91","author":"J Ma","year":"1999","unstructured":"Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst. 1999;91:620\u20135.","journal-title":"J Natl Cancer Inst"},{"key":"1234_CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jnci\/91.2.151","volume":"91","author":"H Yu","year":"1999","unstructured":"Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst. 1999;91:151\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"1234_CR10","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/bjc.2012.19","volume":"106","author":"S Rohrmann","year":"2012","unstructured":"Rohrmann S, Grote VA, Becker S, Rinaldi S, Tj\u00f8nneland A, Roswall N, et al. Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European prospective investigation into cancer and nutrition. Br J Cancer. 2012;106:1004\u201310.","journal-title":"Br J Cancer"},{"key":"1234_CR11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.279.5350.563","volume":"279","author":"JM Chan","year":"1998","unstructured":"Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science. 1998;279:563\u20136.","journal-title":"Science"},{"key":"1234_CR12","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s10552-011-9800-1","volume":"22","author":"SL Park","year":"2011","unstructured":"Park SL, Setiawan VW, Kanetsky PA, Zhang ZF, Wilkens LR, Kolonel LN, et al. Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanoma. Cancer Causes Control. 2011;22:1267\u201375.","journal-title":"Cancer Causes Control"},{"key":"1234_CR13","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/sj.leu.2404813","volume":"21","author":"KT Doepfner","year":"2007","unstructured":"Doepfner KT, Spertini O, Arcaro A. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase\/Akt pathway. Leukemia. 2007;21:1921\u201330.","journal-title":"Leukemia"},{"key":"1234_CR14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/mp.55.1.40","volume":"55","author":"P Vorwerk","year":"2002","unstructured":"Vorwerk P, Wex H, Hohmann B, Mohnike K, Schmidt U, Mittler U. Expression of components of the IGF signalling system in childhood acute lymphoblastic leukaemia. Mol Pathol. 2002;55:40\u20135.","journal-title":"Mol Pathol"},{"key":"1234_CR15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8:915\u201328.","journal-title":"Nat Rev Cancer"},{"key":"1234_CR16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1210\/er.20.6.761","volume":"20","author":"V Hwa","year":"1999","unstructured":"Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev. 1999;20:761\u201387.","journal-title":"Endocr Rev"},{"issue":"3","key":"1234_CR17","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1210\/en.133.3.1462","volume":"133","author":"CE Stewart","year":"1993","unstructured":"Stewart CE, Bates PC, Calder TA, Woodall SM, Pell JM. Potentiation of insulin-like growth factor-I (IGF-I) activity by an antibody: supportive evidence for enhancement of IGF-I bioavailability in vivo by IGF binding proteins. Endocrinology. 1993;133(3):1462\u20135.","journal-title":"Endocrinology"},{"key":"1234_CR18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.exphem.2006.01.009","volume":"34","author":"T Taguchi","year":"2006","unstructured":"Taguchi T, Takenouchi H, Matsui J, Tang WR, Itagaki M, Shiozawa Y, et al. Involvement of insulin-like growth factor-I and insulin-like growth factor binding proteins in pro-B-cell development. Exp Hematol. 2006;34:508\u201318.","journal-title":"Exp Hematol"},{"key":"1234_CR19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2249.1990.tb08090.x","volume":"79","author":"N Kiyokawa","year":"1990","unstructured":"Kiyokawa N, Kokai Y, Ishimoto K, Fujita H, Fujimoto J, Hata JI. Characterization of the common acute lymphoblastic leukaemia antigen (CD10) as an activation molecule on mature human B cells. Clin Exp Immunol. 1990;79:322\u20137.","journal-title":"Clin Exp Immunol"},{"key":"1234_CR20","doi-asserted-by":"crossref","first-page":"18656","DOI":"10.1074\/jbc.272.30.18656","volume":"272","author":"N Kiyokawa","year":"1997","unstructured":"Kiyokawa N, Lee EK, Karunagaran D, Lin SY, Hung MC. Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor. J Biol Chem. 1997;272:18656\u201365.","journal-title":"J Biol Chem"},{"key":"1234_CR21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02075755","volume":"155","author":"KL Mohnike","year":"1996","unstructured":"Mohnike KL, Kluba U, Mittler U, Aumann V, Vorwerk P, Blum WF. Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia. Eur J Pediatr. 1996;155:81\u20136.","journal-title":"Eur J Pediatr"},{"key":"1234_CR22","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/pbc.21450","volume":"50","author":"EA Kolb","year":"2008","unstructured":"Kolb EA, Gorlick R, Houghton PJ, Morton CL, Lock R, Carol H, et al. Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program. Pediatr Blood Cancer. 2008;50:1190\u20137.","journal-title":"Pediatr Blood Cancer"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1234-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-012-1234-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1234-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:11:08Z","timestamp":1559452268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-012-1234-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,19]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["1234"],"URL":"https:\/\/doi.org\/10.1007\/s12185-012-1234-3","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,19]]}}}